Fibroblast growth factor receptor 2 (FGFR2) was demonstrated to correlate to the progression and prognosis of intrahepatic cholangiocarcinoma (ICC) by numerous evidences. However, as a well-recognized suppressor of FGFR2 signalling, the clinical significance of Sprouty (SPRY) family of ICC has not been investigated. In our study, the expressions of SPRY1-4 in 20 pairs of fresh tumour tissues were detected with qPCR, and in 108 cases of paraffin-embedded tissues with immunohistochemistry.
is well acknowledged to promote the progression and lead to poor prognosis of ICC. Two independent studies reported the presence of FGFR2 fusion genes in ICC including FGFR2-AHCYL1, FGFR2-BICC1
and FGFR2-CCDC6, [3] [4] [5] which could activate mitogen-activated protein kinases (MAPK), tumour growth and in vivo tumorigenesis via stimulating the kinase activity of FGFR2. 3 With Integrated genomewide and whole transcriptome sequence analyses, another independent study also demonstrated that FGFR2 downstream signalling pathway was ectopically activated and could be a putative therapeutic target. 6 The autocrine loop of FGFR activation is also demonstrated to promote cholangiocarcinoma progression. 7 In our previous study, we also proved that FGFR4 overexpression correlated with poor prognosis of ICC via promoting proliferation and invasion. can inhibit ERK phosphorylation via modulating different levels of the FGFR-RAS pathway. 10 For example, SPRY2 evidently binds to growth factor receptor-bound protein 2 (GRB2) 
| Tissue microarrays and immunohistochemistry
The tissue microarrays (TMA) of formalin-fixed and paraffinembedded tissue sections were made as to previous report. 21 Before immunohistochemistry (IHC) detection, haematoxylin and eosin staining were performed to confirm the histological characterization of all samples. The protocol of IHC staining was described in detail before. 22 The results of IHC were evaluated independently by two score was the product of the score for staining intensity multiplied by the score for percentage of stained cells, which ranged from 0 to 9. The score with the highest summary of sensitivity and specialty in ROC curve was set as cut-off, which divided the cohort into low and high expression level. The cut-offs of SPRY1,2,3,4 were 3.5, 4.5, 3.5 and 4.5, respectively.
| Cell culture and reagents
The 
| RNA extraction and RT-PCR
The total mRNA of fresh tissues were extracted by Trizol agent High expression of SPRY2 is significantly associated with low overall survival rates, while the other three SPRY members had no remarkable prognostic significance ATTGAGCGGTTTG-3′ and reverse 5′-GGTCAATGGGTAGGAT GGTG-3′.
| Plasmid construction and transfection
SPRY2-Y55F mutation was generated with a Quikchange mutagenesis kit (Stratagene, La Jolla, CA) as previously report and verified by DNA sequencing. 23 The 
| Matrigel invasion assay
Tumour invasion was evaluated in 8-μm-pore Matrigel-coated transwells (BD Biosciences, Franklin Lakes, NJ). Cells were passaged into the matrigel invasion chambers and cultured for 6 hours for adherence, and then incubated in 1%-serum-containing medium with 100 ng/mL FGF1 for 12 hours. After incubating for 24 hours, cells were fixed by 4% paraformaldehyde for 30 minutes and stained by 0.05% gentian violet for 1 hour. Cells on the upper surface were removed with a cotton swab and the cell number on the lower surface was counted from 10 random fields. Cell numbers of control group were set as a baseline and fold change was calculated by ratio to control group. Statistical significance was evaluated by Student's t test. 
| Prognostic value of SPRY family in ICC
The prognostic value of SPRY1-4 was evaluated with both univariate analysis and multivariate analysis. Univariate analysis was first performed to screen the prognostic factors with Kaplan-Meier method (Table 1) . Among the clinicopathological factors, higher tumour size (P = 0.027), positive lymph invasion (P < 0.001) and metastasis (P = 0.014), advanced TNM stage (P < 0.001) could all predict the lower survival rates of ICC patients. In SPRY family, only SPRY2
(P = 0.001) was confirmed as a prognostic biomarker indicating favourable prognosis in ICC (Figure 2A-D) .
The prognostic factors in univariate analysis were all enrolled into Cox-regression model for multivariate analysis (Table 2) , except TNM stage because of its obvious interaction with T, N and M
F I G U R E 3
The correlation between SPRY2 and ICC differentiation. A, The representative images of ICC tissues with different differentiation and SPRY2 expression. ICCs with higher SPRY2 expression appeared to have better differentiation. B, The SPRY2 IHC score of ICC patients with different differentiation. Patients with good differentiation had higher expression of SPRY2 compared with those with poor differentiation. C, ICC with good differentiation had higher SPRY2 mRNA compared with those with poor differentiation, and the mRNA of SPRY2 in adjacent tissues had no significant difference. N.S. means not significant, **P < 0.01, ***P < 0.001 stage. In the multivariate analysis, N stage (P = 0.011, HR = 2.06) and SPRY2 expression (P = 0.021, HR = 1.92) were identified as independent prognostic factors of ICC.
| Correlation between SPRY2 and clinicopathological factors
The correlation between SPRY2 and clinicopathological factors was analysed with Chi-Square test to screen the potential tumour progression processes influenced by SPRY2 (Table 2) . Low expression of SPRY2 was significantly correlated with poor differentiation (P = 0.036) and positive lymphatic invasion (P = 0.013), which suggested that SPRY2 may be involved in the process of ICC invasion.
TNM stage was also associated with SPRY2 expression, and this may be the secondary consequence because of the correlation between SPRY2 and N stage. Figure 4D ).
| SPRY2 suppresses EMT and invasion of ICC
In the clinical analyzation of Table 2 , we observed that SPRY2 expression was significantly associated with ICC differentiation.
As tumour differentiation is an important factor determining tumour invasion, we investigated the role of SPRY2 on ICC cell migration and invasion. With wound healing assay, we proved that FGFR2 knockdown notably impaired the tumour cell migration while silencing SPRY2 could promote migration of RBE or EMT is a generally accepted process inducing invasion and migration and SPRY2 has been reported to influence EMT process in ovarian cancer 24 ; therefore, the influence of SPRY2 on EMT process of ICC was investigated. FGFR inhibitor AP24534 could suppress and attenuate ERK phosphorylation. 25 Due to the redundancy of SPRY family and their multitask mechanism to suppress ERK phosphorylation, the SPRY is generally considered to be cell-and context-specific. Our finding that only SPRY2 in SPRY family correlates to favourable prognosis also supports this suggestion. It is not the main focus to dig out the binding protein of SPRY2
was not identified and the underlying molecular mechanism in ICC, but it is certainly an interesting topic worthy of further study.
In conclusion, we investigated the expression of SPRY family in 
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